Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Novo Nordisk Rebounds After FDA Signals Crackdown on Copycat Drugs
07:36am, Friday, 06'th Feb 2026
Novo Nordisk (NVO) shares rebounded on Friday after comments from the head of the U.S. Food and Drug Administration (FDA) signaled a tougher stance on unapprove
Novo Stock Rises, Hims & Hers Tanks. This Could Shift the Weight-Loss Copycat Battle.
07:04am, Friday, 06'th Feb 2026
Shares in the Danish drugmaker have tanked this week, dragged down by a weak sales outlook and the launch of a Wegovy knockoff.
Hims & Hers falls 8% after Novo's legal threat. Here's the latest
06:44am, Friday, 06'th Feb 2026
Online telehealth company Hims & Hers stock fell Friday after Novo Nordisk said its newly announced Wegovy pill copy was illegal and that it would take legal action. Hims is launching its pill for as
Novo Nordisk stock climbs out of hole on FDA chief's threat to block Hims and Hers pill
04:25am, Friday, 06'th Feb 2026
Novo Nordisk shares rallied on Friday in what's still been a painful week as the Food and Drug Administration may weigh in on the side of the Danish drugmaker in its dispute over a copycat drug.
Hims & Hers' $49 weight-loss pill jolts everyone, except its stock
12:02am, Friday, 06'th Feb 2026
Hims & Hers sent a shockwave through the pharmaceutical industry on Thursday with its announcement of a weight-loss pill with a $49-a-month introductory price. Its shares ended down anyway.
San Francisco, California, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice.
Market Today: Amazon capex, AI selloff, Disney CEO shift
05:36pm, Thursday, 05'th Feb 2026
Stock News Amazon lifts 2026 capex to ~$200B: Amazon (AMZN) posted a Q4 EPS miss but revenue beat and guided 2026 capital expenditures to about $200 billion, pr
Hims & Hers Takes On Novo Nordisk: What We Know Right Now
04:53pm, Thursday, 05'th Feb 2026
Hims and Hers fell on fear that Novo Nordisk would take action against the company's new oral GLP-1, but there's more to the story.
Hims & Hers Launches New Pill That Sends Shockwaves Across Weight-Loss Drugmakers' Stocks
04:27pm, Thursday, 05'th Feb 2026
A new pill from Hims & Hers Health is rattling shares of leading weight-loss drugmakers.
Hims & Hers Launches GRAIL Multi Cancer Screening Test
12:54pm, Thursday, 05'th Feb 2026
Hims and Hers Health (HIMS, Financials) shares jumped nearly 15% in premarket trading after the company said it will offer the Galleri multi cancer detection test
Hims & Hers Launches Compounded Version Of Wegovy, Novo Nordisk Threatens Legal Action
12:51pm, Thursday, 05'th Feb 2026
Starting today, eligible customers can access treatment plans that include Compounded Semaglutide Pills at a special introductory offer starting at just $49 for the first month.
Novo Nordisk Accuses Hims & Hers of ‘Illegal Mass Compounding' Over Cheaper Wegovy Version
12:30pm, Thursday, 05'th Feb 2026
Hims & Hers said it would begin offering copies of Wegovy for an introductory price of $49 for the first month with a five-month plan.
Hims & Hers launches compounded semaglutide pill as lower-cost weight loss option
12:09pm, Thursday, 05'th Feb 2026
Hims & Hers (NYSE:HIMS) has announced the launch of a compounded semaglutide pill designed for weight loss, providing an alternative to Novo Nordisk (NYSE:NVO)'s Wegovy. The oral treatment uses the sa
Novo Nordisk CEO: Hims' $49 compounded Wegovy pill a 'waste' of money
11:38am, Thursday, 05'th Feb 2026
Novo Nordisk CEO Mike Doustdar was in a meeting with investors on Thursday discussing the company's tough recent outlook when one interrupted him with shock news: U.S. telehealth firm Hims and Hers He
Novo Nordisk to take legal action against Hims & Hers for Wegovy compounding
11:11am, Thursday, 05'th Feb 2026
Novo Nordisk said on Thursday it would take legal action against Hims & Hers after the online telehealth company said it will begin offering compounded copies of the Danish group's Wegovy pill at an i
